Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00747734 | A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 35 | Genentech, Inc.INDUSTRY | 0 | Apr 20, 2011 | clinicaltrials |
| NCT00470405 | Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma | completed | Phase 1 | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 18, 2011 | clinicaltrials |
| Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors |
| withdrawn |
| Phase 1 / Phase 2 |
| 100 |
| Hadassah Medical OrganizationOTHER |
| 1 |
| Apr 8, 2011 |
| clinicaltrials |
| NCT00149019 | Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies. | withdrawn | Phase 2 | 12 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00003144 | Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 44 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 30 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004105 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00004030 | VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin | completed | Phase 1 / Phase 2 | 45 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00020748 | Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00670605 | Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center | terminated | — | — | Vanderbilt UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00750425 | Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours | completed | Phase 1 | 46 | AstraZenecaINDUSTRY | 2 | Mar 10, 2011 | clinicaltrials |
| NCT00003294 | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer | completed | Phase 1 | 24 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003882 | Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors | completed | Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003894 | Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant | completed | Phase 2 | 36 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00033566 | S-3304 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00459836 | PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors | completed | Phase 1 | 42 | Proacta, IncorporatedINDUSTRY | 2 | Mar 2, 2011 | clinicaltrials |
| NCT00646139 | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment | completed | Phase 1 | 7 | Roswell Park Cancer InstituteOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00003898 | Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation | completed | Phase 2 | 120 | Roswell Park Cancer InstituteOTHER | 1 | Mar 1, 2011 | clinicaltrials |
| NCT00004875 | Heparin or Enoxaparin in Patients With Cancer | completed | — | 6 | Northwestern UniversityOTHER | 1 | Feb 21, 2011 | clinicaltrials |
| NCT01300468 | Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors | completed | Phase 1 | 38 | Nerviano Medical SciencesINDUSTRY | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00473616 | Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan | terminated | Phase 1 | 60 | AstraZenecaINDUSTRY | 1 | Feb 11, 2011 | clinicaltrials |
| NCT00937664 | Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine | terminated | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00390936 | A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 13 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00605618 | Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 8 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00448786 | Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | completed | Phase 1 | 49 | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT00501605 | Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases | completed | Phase 1 | 80 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00750126 | Allogeneic Hematopoietic Stem Cell Transplantation(RICE) | unknown | Phase 2 | 30 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT00754104 | Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors | withdrawn | Phase 1 | 0 | AbbottINDUSTRY | 0 | Jan 19, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00556088 | LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors | completed | Phase 1 | 40 | SCRI Development Innovations, LLCOTHER | 1 | Dec 30, 2010 | clinicaltrials |
| NCT01021358 | A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). | completed | Phase 1 | 12 | AbbottINDUSTRY | 1 | Dec 20, 2010 | clinicaltrials |
| NCT01019941 | Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer(126ASC08Q) | completed | Phase 1 | 44 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Dec 16, 2010 | clinicaltrials |
| NCT00879554 | A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors(CVX-045-101) | completed | Phase 1 | 40 | PfizerINDUSTRY | 1 | Dec 13, 2010 | clinicaltrials |
| NCT00733031 | Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 | terminated | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT00516438 | Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan | completed | Phase 1 | 48 | AstraZenecaINDUSTRY | 1 | Dec 8, 2010 | clinicaltrials |
| NCT00413686 | Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies | completed | Phase 1 | 42 | AstraZenecaINDUSTRY | 1 | Dec 6, 2010 | clinicaltrials |
| NCT01226030 | Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 21, 2010 | clinicaltrials |
| NCT01226056 | Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets | suspended | Phase 1 / Phase 2 | 45 | Southern Europe New Drug OrganizationOTHER | 1 | Oct 21, 2010 | clinicaltrials |
| NCT00801177 | Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy | completed | Phase 1 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT01220284 | Satraplatin and Vinorelbine in Advanced Solid Tumors | unknown | Phase 1 | 27 | Southern Europe New Drug OrganizationOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00782002 | Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy | completed | Phase 1 | 27 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 30, 2010 | clinicaltrials |
| NCT00006086 | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer | completed | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00778128 | A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour | completed | Phase 1 | 26 | Clavis PharmaINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00002915 | Penclomedine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00047242 | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00368914 | Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00692354 | Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours | completed | Phase 1 | 41 | Chroma TherapeuticsINDUSTRY | 0 | Aug 6, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Apr 20, 2011source: clinicaltrials